Brainomix’s e-Stroke software goes live across Sussex

May 4, 2021


Brainomix’s e-Stroke software was recently deployed across University Hospitals Sussex NHS Foundation Trust, with the software now live at Royal Sussex County Hospital in Brighton, Worthing Hospital, and at St Richard’s Hospital in Chichester. The trust is one of the largest acute trusts in the UK, covering West Sussex, Brighton and Hove, and parts of East Sussex, hosting more than 1.5 million outpatient appointments, A&E visits and surgical cases each year.

“At a local level, this decision support tool will help us to speed up diagnosis and therefore patient care in a simple and safe way. From a Sussex perspective, the implementation of Brainomix across the region will support the highly specialized thrombectomy pathway, facilitating the timely transfer of those eligible for treatment to the specialist hubs. For both patients and clinicians having access to this support, no matter where they live in Sussex, is a real step forward for stroke care.”

Dr Ingrid Kane, a Consultant Stroke Physician at Royal Sussex County Hospital


Stroke affects 110,000 people each year in the UK and it’s the 4th largest cause of death.

8 out of 10 stroke patients who leave the hospital do so with a disability. As a result, stroke costs UK society £26 billion per year. The most severe and disabling strokes are due to a large vessel occlusion (LVO).

The Sussex Integrated Stroke Delivery Network has driven the rollout of the e-Stroke software as part of its system-wide working across Sussex Health and Care Partnership and the plan is for this to be further rolled out across the ICS footprint.

The roll-out of e-Stroke in the region is part of a larger project resulting from a prestigious NHSX AI award to Brainomix in September 2020, enabling the company to deploy its software across five UK stroke networks to assess its “real world” impact on patient care.

“NCIMI are delighted to continue our successful and long-standing collaboration with Brainomix to expand the use of stroke AI into the clinical pathway at University Hospitals Sussex.  This is part of a wider regional multi-centered initiative to deliver improved patient outcomes and to generate new insights and learning for the NHS – both about AI adoption challenges in general and the specifics of integrating AI into the stroke care pathway.”

Dr Claire Bloomfield, NCIMI CEO


Brainomix specialises in the creation of AI-powered imaging biomarkers to enable precision medicine for better treatment decisions.

They launched in 2010 when they spun out of the University of Oxford.

They have developed awards-winning AI-powered imaging biomarkers and software solutions, assisting physicians across the world to make better life-saving decisions.

“Our partnership with NCIMI has been instrumental in helping to accelerate the adoption of our software across the extended Thames Valley regional stroke network, empowering clinicians to make faster, more confident treatment decisions, ultimately improving patient care.”

Dr Michalis Papadakis, CEO & Co-Founder, Brainomix